General
Preferred name
Aminoimidazole carboxamide
Synonyms
4-Amino-5-imidazolecarboxamide ()
AICA ()
5-Aminoimidazole-4-carboxamide ()
orazamide ()
5-Amino-3H-imidazole-4-Carboxamide ()
5-Amino-4-imidazolecarboxamide ()
5-Aminoimidazole-4-carboxamide (hydrate) ()
P&D ID
PD073653
CAS
360-97-4
21299-72-9
Tags
available
drug
Drug Status
approved
investigational
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION 5-Amino-3H-imidazole-4-Carboxamide (AICA) is an important precursor for the synthesis of purines in general and of the nucleobases adenine and guanine in particular[1][2][3].
PRICE 29
DESCRIPTION 5-Amino-3H-imidazole-4-Carboxamide (AICA) is an imidazole derivative and a metabolite of the antineoplastic agents BIC and DIC. It serves as a condensation agent in the preparation of nucleosides and nucleotides, and when compounded with orotic acid, it is used to treat liver diseases. (TargetMol Bioactive Compound Library)
DESCRIPTION 5-Amino-4-imidazolecarboxamide is an imidazole derivative. (TargetMol Bioactive Compound Library)
Compound Sets
9
Cayman Chemical Bioactives
DrugBank
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
69
Properties
(calculated by RDKit )
Molecular Weight
126.05
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.91
TPSA
97.79
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
5.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data